title: Gene expression patterns in myelodyplasia underline the role of apoptosis and differentiation in disease initiation and progression.
abstract: The myelodysplastic syndromes (MDS) are clonal stem cell disorders, characterized by ineffective and dysplastic hematopoiesis. The genetic and epigenetic pathways that determine disease stage and progression are largely unknown. In the current study we used gene expression microarray methodology to examine the gene expression differences between normal hematopoietic cells and hematopoietic cells from patients with MDS at different disease stages, using both unselected and CD34+ selected cells. Significant differences between normal and MDS hematopoietic cells were observed for several genes and pathways. Several genes promoting or opposing apoptosis were dysregulated in MDS cases, most notably MCL1 and EPOR. Progression from RA to RAEB(T) was associated with increased expression of several histone genes. In addition, the RAR-RXR pathway, critical for maintaining a balance between self-renewal and differentiation of hematopoietic stem cells, was found to be deregulated in hematopoietic cells from patients with advanced MDS compared to patients with refractory anemia. These findings provide new insights into the understanding of the pathophysiology and progression of MDS, and may guide to new targets for therapy. Taken together with previous published data, the present results also underscore the considerable complexity of the regulation of gene expression in MDS.
authors.affiliation: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
authors.forename: Merav
authors.initials: M
authors.lastname: Bar
authors.forename: Derek
authors.initials: D
authors.lastname: Stirewalt
authors.forename: Era
authors.initials: E
authors.lastname: Pogosova-Agadjanyan
authors.forename: Vitas
authors.initials: V
authors.lastname: Wagner
authors.forename: Ted
authors.initials: T
authors.lastname: Gooley
authors.forename: Nissa
authors.initials: N
authors.lastname: Abbasi
authors.forename: Ravi
authors.initials: R
authors.lastname: Bhatia
authors.forename: H Joachim
authors.initials: HJ
authors.lastname: Deeg
authors.forename: Jerald
authors.initials: J
authors.lastname: Radich
references.citation: Exp Hematol. 2000 Jul;28(7):784-91
references.pmid: 10907640
references.citation: Br J Haematol. 1998 Oct;103(1):176-88
references.pmid: 9792306
references.citation: Br J Haematol. 2008 Feb;140(4):444-53
references.pmid: 18162123
references.citation: N Engl J Med. 1999 May 27;340(21):1649-60
references.pmid: 10341278
references.citation: N Engl J Med. 2003 Nov 20;349(21):2042-54
references.pmid: 14627790
references.citation: Leukemia. 1994 Apr;8(4):638-41
references.pmid: 7512175
references.citation: Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9440-5
references.pmid: 12883005
references.citation: Leuk Lymphoma. 2000 Apr;37(3-4):405-14
references.pmid: 10752992
references.citation: Br J Haematol. 2000 Sep;110(4):876-9
references.pmid: 11054073
references.citation: Nat Rev Cancer. 2006 Jan;6(1):38-51
references.pmid: 16397526
references.citation: Int J Hematol. 2004 Aug;80(2):140-5
references.pmid: 15481442
references.citation: Acta Haematol. 2003;109(1):29-34
references.pmid: 12486320
references.citation: Gene. 2004 Mar 17;328:1-16
references.pmid: 15019979
references.citation: Nat Rev Genet. 2002 Jun;3(6):415-28
references.pmid: 12042769
references.citation: Blood. 2002 Aug 1;100(3):791-8
references.pmid: 12130488
references.citation: Cell. 2003 Nov 26;115(5):537-49
references.pmid: 14651846
references.citation: Blood. 2007 Feb 15;109(4):1620-6
references.pmid: 17062731
references.citation: Leukemia. 2003 Dec;17(12):2460-6
references.pmid: 14562111
references.citation: Haematologica. 2001 Oct;86(10):1038-45
references.pmid: 11602409
references.citation: Int J Biochem Cell Biol. 2005 Feb;37(2):267-71
references.pmid: 15474972
references.citation: Cancer Res. 2006 Jun 15;66(12):6210-8
references.pmid: 16778195
references.citation: Br J Haematol. 2004 Jun;125(5):576-83
references.pmid: 15147372
references.citation: Haematologica. 1998 Jan;83(1):71-86
references.pmid: 9542325
references.citation: Leuk Res. 1999 Mar;23(3):239-46
references.pmid: 10071075
references.citation: Clin Lab Haematol. 2006 Apr;28(2):126-9
references.pmid: 16630218
references.citation: J Exp Med. 2006 May 15;203(5):1283-93
references.pmid: 16682494
references.citation: Hematology. 2005 Aug;10(4):281-7
references.pmid: 16085540
references.citation: Stem Cells. 2004;22(4):590-9
references.pmid: 15277704
references.citation: Curr Top Microbiol Immunol. 2006;302:145-67
references.pmid: 16620028
references.citation: Int J Cancer. 2003 Nov 1;107(2):202-8
references.pmid: 12949795
references.citation: Mol Cancer Ther. 2006 Feb;5(2):356-61
references.pmid: 16505109
references.citation: Best Pract Res Clin Haematol. 2001 Sep;14(3):479-95
references.pmid: 11640866
references.citation: Genomics. 2004 Feb;83(2):321-31
references.pmid: 14706461
references.citation: Leukemia. 1995 Nov;9(11):1818-21
references.pmid: 7475268
references.citation: Blood. 2001 Sep 15;98(6):1914-21
references.pmid: 11535529
references.citation: Cell. 2003 Nov 26;115(5):508-10
references.pmid: 14651842
references.citation: Br J Haematol. 2000 Sep;110(3):584-90
references.pmid: 10997968
references.citation: Int J Hematol. 2001 Jun;73(4):429-437
references.pmid: 11503956
references.citation: Semin Hematol. 1996 Apr;33(2):127-38
references.pmid: 8722683
references.citation: Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
references.pmid: 16199517
references.citation: PLoS Med. 2008 Feb;5(2):e35
references.pmid: 18271621
references.citation: Cell Signal. 2004 Oct;16(10):1085-104
references.pmid: 15240004
references.citation: Leukemia. 1994 Aug;8(8):1331-6
references.pmid: 8057669
references.citation: Blood. 2002 Feb 1;99(3):746-53
references.pmid: 11806973
references.citation: Mayo Clin Proc. 2005 May;80(5):681-98
references.pmid: 15887439
references.citation: Biochem Pharmacol. 2006 Nov 30;72(11):1563-9
references.pmid: 16836980
references.citation: Nephron. 2001 Mar;87(3):215-22
references.pmid: 11287756
references.citation: Eur J Haematol. 2006 Jan;76(1):23-32
references.pmid: 16343268
references.citation: Leuk Res. 2002 Oct;26(10):899-902
references.pmid: 12163050
references.citation: Cancer. 2004 Sep 1;101(5):989-98
references.pmid: 15329908
references.citation: Br J Haematol. 1982 Jun;51(2):189-99
references.pmid: 6952920
references.citation: Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21
references.pmid: 11309499
references.citation: Nucleic Acids Res. 1996 Feb 1;24(3):486-93
references.pmid: 8602362
references.citation: Blood. 2002 Nov 15;100(10):3553-60
references.pmid: 12411319
references.citation: Br J Haematol. 2003 Mar;120(6):1037-46
references.pmid: 12648074
references.citation: Br J Haematol. 1986 May;63(1):149-59
references.pmid: 3707860
references.citation: Clin Immunol. 2004 Dec;113(3):310-7
references.pmid: 15507396
references.citation: Curr Hematol Rep. 2003 Mar;2(2):122-9
references.pmid: 12901143
references.citation: Leuk Res. 2005 Feb;29(2):215-24
references.pmid: 15607371
references.citation: Blood. 2006 Jul 1;108(1):337-45
references.pmid: 16527891
references.citation: Science. 2005 Feb 18;307(5712):1101-4
references.pmid: 15718471
references.citation: Blood. 1998 Apr 15;91(8):2985-90
references.pmid: 9531610